Physician

Mark Lee Sczepanski, M.D.

According to 2025 Medicare claims, Mark Sczepanski, M.D. (NPI: 1295731040) practices ophthalmology in the Grand Forks, ND-MN market, with the plurality of this provider's patient population coming from Grand Forks, ND. This provider's primary affiliated billing organization is NORTH DAKOTA EYE CLINIC, LTD (NPI: 1972563815; TIN: 450309162) and primary practice location at 58201-3642. Sczepanski is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Sczepanski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,171 traditional Medicare patients, billed 4,234 HCPCS/CPT codes, and received $595,095 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 2,434 prescription claims across 515 beneficiaries totaling $377,059 in drug costs, led by Lumigan (Bimatoprost). DME data shows 184 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $375,639 to $595,095. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $212,884 and ending at $377,059. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,182	3,539	$375,639
2016	1,120	3,298	$352,317
2017	1,195	3,310	$381,272
2018	1,182	3,735	$458,295
2019	1,434	4,209	$535,844
2020	1,520	5,212	$565,296
2021	1,515	4,777	$605,298
2022	1,224	4,066	$570,277
2023	1,129	4,117	$567,516
2024	1,171	4,234	$595,095

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	596	2,559	$212,884
2016	587	2,642	$215,083
2017	357	1,707	$166,357
2018	413	1,836	$181,606
2019	487	1,998	$194,719
2020	503	2,519	$318,629
2021	528	2,490	$256,088
2022	505	2,352	$311,938
2023	523	2,229	$171,735
2024	515	2,434	$377,059

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	91	91	$5,825
2016	74	74	$4,802
2017	100	100	$5,951
2018	63	74	$5,051
2019	175	178	$11,589
2020	143	143	$9,443
2021	62	63	$4,232
2022	145	146	$10,672
2023	165	165	$11,363
2024	183	184	$13,866

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
66984	Removal of cataract with insertion of prosthetic lens	549	921	$357
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	349	349	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	203	204	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	296	444	$60
92136	Measurement of corneal curvature and depth of eye	639	967	$29

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lumigan	Bimatoprost	104	3,040	$31,892
Prednisolone Acetate	Prednisolone Acetate	378	11,463	$23,171
Rocklatan	Netarsudil Mesylat/Latanoprost	49	1,408	$18,365
Rhopressa	Netarsudil Mesylate	22	637	$9,942
Combigan	Brimonidine Tartrate/Timolol	30	885	$7,361

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2020	Frames, purchases	N	83	83	$4,338
V2303	Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens	N	36	36	$3,414
V2203	Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens	N	28	29	$2,491
V2200	Sphere, bifocal, plano to plus or minus 4.00d, per lens	N	24	24	$2,278
V2300	Sphere, trifocal, plano to plus or minus 4.00d, per lens	N	12	12	$1,346

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Mark Lee Sczepanski, M.D.?

Tedicare shows public-source Medicare data for Mark Lee Sczepanski, M.D. (NPI 1295731040), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Lee Sczepanski, M.D. have ACO affiliation data?

Mark Lee Sczepanski, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Mark Lee Sczepanski, M.D.?

Mark Lee Sczepanski, M.D. is linked to NORTH DAKOTA EYE CLINIC, LTD (billing NPI 1972563815) in the available physician profile data.

Does Mark Lee Sczepanski, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.